{"id":"W4389230430","doi":"10.1182/blood-2023-179305","title":"Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"B-cell activating factor; Medicine; Autoimmune hemolytic anemia; Immunology; Rituximab; Autoantibody; Antibody; Evans syndrome; Systemic lupus erythematosus; Internal medicine; B cell; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00247585,0.001067589,0.001240443,0.000426495,0.0004030765,0.0009388711,0.0007830425,0.001545752,0.002119193],"category_scores_gemma":[0.0009653709,0.0002659132,0.001034556,0.0002951771,0.0007284839,0.0006224518,0.0004004604,0.002138311,0.001014241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006926648,"about_ca_system_score_gemma":0.0008623961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006009716,"about_ca_topic_score_gemma":0.0005690039,"domain_scores_codex":[0.9993758,0.0002515765,0.00006840166,0.0000893253,0.00008029718,0.000134741],"domain_scores_gemma":[0.9992796,0.0002401059,0.00007613566,0.0000978199,0.00009277393,0.00021363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0535732,0.02514151,0.01778195,0.002707562,0.001578853,0.01208519,0.001012518,0.001680664,0.4540269,0.002500688,0.01220948,0.4157015],"study_design_scores_gemma":[0.04636482,0.3991043,0.05570924,0.0003749647,0.002385657,0.02832895,0.0002701723,0.002435563,0.3211268,0.001538327,0.1422245,0.0001367259],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9362897,0.03320822,0.00518822,0.002297233,0.0004175233,0.001715947,0.001280624,0.0003276553,0.01927478],"genre_scores_gemma":[0.9784494,0.009429664,0.002012589,0.002318325,0.0006440998,0.0005873406,0.001333536,0.00004531521,0.005179663],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00247585,"threshold_uncertainty_score":0.01309365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02489560194853654,"score_gpt":0.3130018678597655,"score_spread":0.288106265911229,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}